• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Tapestry: Investment Portfolio & Startup News

Tapestry

To add a bio or update investment portfolio click update information.

Investment Portfolio

    Nothing lands £150m Series C led by Tiger Global to build out AI smartphone platformNothing lands £150m Series C led by Tiger Global to build out AI smartphone platform
    Nothing
    16 Sept 2025

    Nothing lands £150m Series C led by Tiger Global to build out AI smartphone platform

    Nothing designs consumer technology that integrates hardware and software into an AI-native platform, starting with smartphones and expanding across connected devices.

    Gen Phoenix lands £11m led by Material Impact as Tapestry deepens strategic partnership in circular leather innovationGen Phoenix lands £11m led by Material Impact as Tapestry deepens strategic partnership in circular leather innovation
    Gen Phoenix
    15 Jul 2025

    Gen Phoenix lands £11m led by Material Impact as Tapestry deepens strategic partnership in circular leather innovation

    Gen Phoenix manufactures recycled leather fibre materials at scale, transforming leather waste into durable, circular alternatives for fashion and accessories brands.

Tapestry
    • Consumer
    • Climate
  • tapestry.com

More venture news

  • Isomorphic Labs unlocks a £3.8bn Series C round led by Greenoaks and Sequoia Capital to design new medicines with AI
    Isomorphic Labs
    17 Nov 2026

    Isomorphic Labs unlocks a £3.8bn Series C round led by Greenoaks and Sequoia Capital to design new medicines with AI

    Series CLife Sciences
  • Fractile raises a £540m Series C from investors including Thrive and Founders Fund to build the chips that AI frontiers run on
    Fractile
    11 Nov 2026

    Fractile raises a £540m Series C from investors including Thrive and Founders Fund to build the chips that AI frontiers run on

    Series CDeep Tech
  • OMass Therapeutics raises a £230m Series C round from VCs including Bain Capital to develop small molecule therapeutics with drug discovery platform
    OMass Therapeutics
    15 Oct 2026

    OMass Therapeutics raises a £230m Series C round from VCs including Bain Capital to develop small molecule therapeutics with drug discovery platform

    Series CLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn